title: Selectively targeting the DNA-binding domain of the androgen receptor as a prospective therapy for prostate cancer.
authors.forename: Kush
authors.initials: K
authors.lastname: Dalal
authors.forename: Mani
authors.initials: M
authors.lastname: Roshan-Moniri
authors.forename: Aishwariya
authors.initials: A
authors.lastname: Sharma
authors.forename: Huifang
authors.initials: H
authors.lastname: Li
authors.forename: Fuqiang
authors.initials: F
authors.lastname: Ban
authors.forename: Mohamed D
authors.initials: MD
authors.lastname: Hassona
authors.forename: Michael
authors.initials: M
authors.lastname: Hsing
authors.forename: Kriti
authors.initials: K
authors.lastname: Singh
authors.forename: Eric
authors.initials: E
authors.lastname: LeBlanc
authors.forename: Scott
authors.initials: S
authors.lastname: Dehm
authors.forename: Emma S
authors.initials: ES
authors.lastname: Tomlinson Guns
authors.forename: Artem
authors.initials: A
authors.lastname: Cherkasov
authors.forename: Paul S
authors.initials: PS
authors.lastname: Rennie